Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Interpreting cost analyses of clinical interventions

Article Abstract:

Reports of clinical trials in medical journals often contain comments about the costs of a medical intervention without providing cost data. Researchers reviewed 181 articles that included statements of cost and found that 53.6% contained actual data. Articles with cost data most often cited operating expenses, such as supplies and personnel, and rarely considered overhead or start-up costs in estimating the cost-effectiveness of a medical treatment or procedure. A standardized protocol for reporting the cost of clinical interventions would help physicians better perform cost-benefit analyses.

Author: West, Timothy D., Centor, Robert M., Soderstrom, Naomi S., Gupta, Mahendra, West, David A., Balas, E. Andrew, Boren, Suzanne Austin, Kretschmer, Rainer A.C., Gnann, Wolfgang, Nerlich, Michael
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
Evaluation, Reports, Medical care, Cost of, Health care costs, Cost benefit analysis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Financial Interest and Its Disclosure in Scientific Publications

Article Abstract:

Biomedical journals can best serve the scientific community and the public by requiring all authors to disclose any financial conflict of interest. The most important conflict of interest is any financial relationship with industry such as employment, consultancies, stock ownership, honoraria, or expert testimony. Some editors believe in prohibiting conflicts of interest whereas others merely require the author to disclose such interests. Journals differ substantially in their requirements to disclose financial interests to editors.

Author: Krimsky, Sheldon PhD, Rothenberg, L. S. JD
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
Ethical aspects, Medical publishing, Conflict of interests (Agency), Conflicts of interest

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Scientific and Ethical Issues in Equivalence Trials

Article Abstract:

The difficulties in conducting equivalence trials are discussed. Most clinical trials assume that both treatments are equivalent and then try to determine if one is actually better than the other. An equivalence trial assumes one treatment is better than another and then tries to determine if they are actually equivalent.

Author: Djulbegovic, Benjamin, Clarke, Mike
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
Editorial, Drugs

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Analysis, Clinical trials
Similar abstracts:
  • Abstracts: Infection control basis for recommending one-time use of sterile syringes and aseptic procedures for injection drug users
  • Abstracts: Gene-diet interactions in brain aging and neurodegenerative disorders. Interactions between Apolipoprotein E and Apolipoprotein(a) in Patients with Late-Onset Alzheimer Disease
  • Abstracts: Ambulatory blood-pressure monitoring in clinical practice. Seasonal changes in blood pressure in patients with end-stage renal disease treated with hemodialysis
  • Abstracts: The challenges of emerging infectious diseases: development and spread of multiply-resistant bacterial pathogens
  • Abstracts: Problematic variation in local institutional review of a multicenter genetic epidemiology study. Genetic Information, Genomic Technologies, and the Future of Drug Discovery
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.